Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 19, 2020ViewOpen Access

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2020 study studied this question.

synapsesocial.com/papers/6aa212942fd346a5956ee6cdhttps://doi.org/10.1016/s0140-6736(20)32466-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2020 · 2,746 citations
  2. 2Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes2020 · 805 citations
  3. 3Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years2020 · 111 citations
  4. 4A global clinical measure of fitness and frailty in elderly people2005 · 9,225 citations